1.
Med J Aust
; 1(12): 550, 1979 Jun 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-470726
RESUMO
A patient with mild chronic renal failure developed significant hyperkalaemia while receiving indomethacin therapy. The hyperkalaemia, which was reversed by discontinuing indomethacin, is attributed to a drug-induced defect in the cellular uptake of potassium.